focus -WSS

focus

author：leisure time 2025-10-01 23:31:06 - browse：83

Adobe

WASHINGTON — The federal government increasingly is scrutinizing Chinese businesses and their interactions with American companies, including in the biotech sector. Chinese biotechnology companies, the thinking goes, could threaten national security by giving the Chinese government access to the genetic and health information of Americans.

Just Wednesday, President Biden issued an executive order aimed at keeping sensitive data, including Americans’ genetic information, out of the hands of adversaries.

But American biotech companies worry they could become collateral damage if the government sloppily targets sanctions. They’re pushing back against legislation that would bar biotech companies from working with some Chinese companies, especially as the government takes aim at WuXi, a Chinese company considered a crucial partner for discovering, testing, and making medicines that has worked with such brands as Pfizer, AstraZeneca, and GSK.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Fentanyl is making it harder to start addiction treatment

focus

WSS

The battle over the Brookhaven Landfill on Long Island

Obesity experts on risks of Wegovy, Ozempic weight loss drugs

Why we need to separate burnout from moral injury in health care

Why we need to separate burnout from moral injury in health care

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Investigation reveals sickle cell patients pressured into sterilizations

hotspot

focus

focus

Medicare details structure of new drug price negotiation program

Digital health: a case of mistaken identity

Walensky prepares to leave CDC — and Congress — behind

Scrutiny of post

Psychedelics group wrestles with new pharma identity

Cue Health, Covid

What does generative AI mean for health care? We asked experts

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

CDC concerned about possible undetected monkeypox spread in U.K.

Wikipedia

H5N1 bird flu outbreak: Second human case reported, in Michigan

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

The battle over the Brookhaven Landfill on Long Island

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

The science behind Janet Jackson's pregnancy at 49

entertainment

focus

explore

hotspot